Medical Device Firm Anticipates Benefit from Patent Ruling

  ()
This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent. read more >

Medical Device Firm's Clinical Programs Progress in Q2/18

Research Report
  ()
A Ladenburg Thalmann report reviewed the recent financial results for a California-based company that has developed treatments for vaginal laxity and female stress urinary incontinence. read more >

Biotech Marks Progress on Programs for Cancer, Infectious Diseases

Research Report
  ()
This firm, focused on immuno-oncology and infectious diseases including Ebola and Zika, is moving forward on a variety of fronts, according to a Maxim Group analyst. read more >

Biopharma Signs Multimillion-Dollar Deal for Key Products in China

Research Report
  ()
An H.C. Wainwright & Co. report reviewed the arrangement. read more >

Biotech Releases White Paper on Alzheimer's Disease Candidate

  ()
A company focused on treatment of neurodegenerative diseases has issued a white paper discussing its lead candidate. read more >

Cash Stream from Licensing Deal to Help Biopharma Advance Lead Drug

Research Report
  ()
A Laidlaw & Co. report discussed this firm's revenue and near-term, clinical catalysts. read more >
News Update

U.S. Medical Device Firm Pursues ISO 13485 Certification

News Update
  ()
With this move, this company aims for fast-tracked regulatory approval for its nitric oxide delivery system. read more >

Interim Readout for Pharma Trial 'Delivers Home Run'

Research Report
  ()
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. read more >

Biopharma Releases New Antibiotic in the US for Complicated UTIs

Research Report
  ()
A LifeSci Capital report reviewed why uptake of a drug that targets complicated urinary tract infections could be significant and swift. read more >

Health Technology Stock 'Set to Break Higher'

Contributed Opinion
  ()
Technical analyst Clive Maund charts a health technology stock whose platform allows hospitals and healthcare organizations to buy, sell and trade surplus medical equipment and supplies. read more >
Expert Investing Ideas

"DRRX's total revenue for Q2/18 was $3.4M."

–Grant Zeng, Zacks Small-Cap Research


"We consider DRRX a development story."

–Francois Brisebois, Laidlaw & Company


"We are initiating coverage on PMN."

–John Vandermosten, Zacks Small-Cap Research


"DRRX reported its Q1/18, mostly in line with expectations."

–Francois Brisebois, Laidlaw & Company


"PMN is seeking to forge partnerships with big pharmas."

–André Uddin, Mackie Research Capital


321 Gold

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Australian Regenerative Medicine Firm 'Lands a Great Partner in China'

Research Report
  ()
A Maxim Group report reviewed the deal between the two companies. read more >
News Update

Healthcare Tech Company Receives US Patent

News Update
  ()
The U.S Patent and Trademark Office has granted the allowance to a technology company whose platform allows healthcare organizations to buy, sell and trade equipment and supplies. read more >

Cannabis Firm Targets Sexual Health and Wellness

Contributed Opinion
  ()
California, with nearly 40 million residents, offers a cannabis market as large as the whole of Canada, says Ron Struthers, editor of Struthers Resource Stock Report. He believes that companies that have a road into California will gain early traction, and he profiles one such firm. read more >
News Update

Cell Therapy Company and Chinese Firm Sign Marketing Deal

  ()
This biotech, in Phase 1 development of regenerative technologies addressing skin and orthopedic indications, has finalized a commercialization deal with YOFOTO. read more >